Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril chronotherapy in hypertension with obstructive sleep apnoea
ACTRN12611000216910Phase 4Completed
- Sponsor
- Dr C Phillips - Principle Investigator
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of perindopril in hypertension (HTN) (2 arms), sponsored by Dr C Phillips - Principle Investigator. Primary endpoint: Nighttime systolic blood pressure. Started Mar 2011; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12611000216910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000216910.